Tablet for treating radiation thyroiditis and preparation method thereof
A thyroiditis and radioactive technology is applied in the field of tablets for the treatment of radiation thyroiditis and the field of preparation thereof to achieve the effects of enhancing body immunity, stabilizing drug efficacy, and improving local microcirculation and nutrient supply
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0016] A tablet for the treatment of radiation thyroiditis, said tablet, by weight, mainly comprises: 1.0 part of hydrocortisone, 0.8 part of cyclosporine, 0.6 part of emodin, 0.3 part of cefotiam axetil, naphthalene Bumethone 0.5 parts, lentinan 2.4 parts, naringin 1.2 parts, Triticein 0.6 parts, Syringic acid 0.3 parts, Glycopeptides 4.2 parts, Vitamin K1 0.1 parts, Peonyol 0.6 parts, Succinic acid 0.5 parts, Vitamins E0.6 parts and 8 parts of hydroxypropyl methylcellulose; the tablet also includes auxiliary materials: 55 parts of fillers, 0.8 parts of disintegrants, and 1.2 parts of lubricants.
[0017] Among them, the filler lactose, microcrystalline cellulose or beta cyclodextrin one or a mixture of several, without toxic side effects, is a commonly used tablet additive. The disintegrant is one or a mixture of crospovidone, sodium carboxymethyl starch, or calcium carboxymethyl cellulose, which exerts strong swelling properties during the preparation of the drug, and is compa...
Embodiment 2
[0023] A tablet for the treatment of radiation thyroiditis, said tablet, in terms of weight components, mainly comprises: 2.0 parts of hydrocortisone, 1.0 part of cyclosporin, 0.8 part of emodin, 0.4 part of cefotiam axetil, naphthalene 0.65 parts of Bumethone, 3.0 parts of lentinan, 1.5 parts of Naringin, 0.9 parts of Tritice, 0.45 parts of Syringic acid, 5.5 parts of Glycopeptides, 0.2 parts of Vitamin K1, 0.7 parts of Peonyol, 0.7 parts of Succinic Acid, Vitamins E0.7 parts and 10 parts of hydroxypropyl methylcellulose; the tablet also includes auxiliary materials: 65 parts of filler, 1.0 part of disintegrant, and 1.4 parts of lubricant.
[0024] Among them, one or more of the fillers lactose, microcrystalline cellulose or betacyclodextrin are mixed without toxic and side effects, and are commonly used tablet additives. The disintegrant is one or a mixture of crospovidone, sodium carboxymethyl starch, or calcium carboxymethyl cellulose, which exerts strong swelling properties ...
Embodiment 3
[0030] A tablet for the treatment of radiation thyroiditis, said tablet, in terms of weight components, mainly comprises: 3.0 parts of hydrocortisone, 1.2 parts of cyclosporine, 1.0 part of emodin, 0.5 part of cefotiam axetil, naphthalene 0.8 parts of bumethone, 3.6 parts of lentinan, 1.8 parts of naringin, 1.2 parts of Triticein, 0.6 parts of syringic acid, 6.8 parts of glycopeptides, 0.3 parts of vitamin K1, 0.8 parts of peonyol, 0.9 parts of succinic acid, vitamins 0.8 parts of E and 12 parts of hydroxypropyl methylcellulose; the tablet also includes auxiliary materials: 75 parts of fillers, 1.2 parts of disintegrants, and 1.6 parts of lubricants.
[0031] Among them, one or more of the fillers lactose, microcrystalline cellulose or betacyclodextrin are mixed without toxic and side effects, and are commonly used tablet additives. The disintegrant is one or a mixture of crospovidone, sodium carboxymethyl starch, or calcium carboxymethyl cellulose, which exerts strong swelling p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com